Pfizer announces major share sale in Haleon plc alongside a strategic share buyback
LONDON, UK: Pfizer Inc. has declared its intention to offload a substantial portion of its shares in Haleon plc. The transaction involves approximately 630 million ordinary shares, including those represented by American Depositary Shares (ADSs), through a dual public offering in the United States and an international offering to qualified investors. The pricing for this…